From: Impact of Preoperative Immunonutritional Support in Patients Undergoing Elective Thoracic Surgery
| Items | No. (%) or Median (Range) | |
|---|---|---|
| Gender | Male | 20 (52.5) |
| Female | 19 (47.5) | |
| Age | 72 (21-89) | |
| ECOG-PS | 0 | 35 (89.7) |
| 1 | 4 (10.3) | |
| Body balance | Body height (cm) | 158 (140-176) |
| Body weight (kg) | 56.6 (37.0-86.0) | |
| Preoperative diagnosis | Lung cancer | 26 (67.5) |
| Metastatic lung tumors | 9 (22.5) | |
| Others | 4 (10.0) | |
| Smoking status | Non | 19 (48.7) |
| Current | 3 (7.7) | |
| Former | 17 (43.6) | |
| Comorbidities | Hypertension | 13 (33.3) |
| Type 2 diabetes mellitus | 8 (20.5) | |
| Other malignancies | 8 (20.5) | |
| Cerebral infarction | 6 (15.4) |
From: Impact of Preoperative Immunonutritional Support in Patients Undergoing Elective Thoracic Surgery
| Items | Baseline | After support | Mean difference (95% CI) |
|---|---|---|---|
| Body weight (kg) | 58.9 ± 1.9 | 59.4 ± 1.9 | 0.4 (−0.2 to 1.0) |
| Complete blood cell counts | |||
| White blood cell count (/μL) | 5.582 ± 291 | 5,726 ± 257 | 143.6 (−216.4 to 503.6) |
| Neutrophils (/μL) | 3,724 ± 233 | 3,776 ± 221 | 51.8 (−281.3 to 384.8) |
| Lymphocytes (/μL) | 1,282 ± 57 | 1,384 ± 76 | 102.0 (−15.4 to 219.5) |
| Monocytes (/μL) | 324 ± 20 | 355 ± 21 | 31.5 (−1.1 to 64.1) |
| Eosinophils (/μL) | 231 ± 60 | 172 ± 28 | −59.2 (−169.1 to 50.8) |
| Basophils (/μL) | 36 ± 3 | 37 ± 4 | 1.7 (−3.4 to 6.9) |
| Hemoglobin (g/dL) | 12.6 ± 0.3 | 12.7 ± 0.3 | 0.1 (−0.2 to 0.3) |
| Hematocrit (%) | 38.0 ± 0.8 | 38.1 ± 0.8 | 0.0 (−0.5 to 0.6) |
| RDW (%) | 14.3 ± 0.5 | 14.1 ± 0.3 | −0.2 (−0.7 to 0.3) |
| Platelet (× 103/μL) | 218 ± 12 | 217 ± 11 | −0.5 (−11.5 to 10.4) |
| Serum chemistry | |||
| Albumin (g/dL) | 4.1 ± 0.1 | 4.2 ± 0.1 | 0.1 (0.0 to 0.2) |
| Total cholesterol (mg/dL) | 196 ± 10 | 191 ± 5 | −5.0 (−12.7 to 2.7) |
| Triglyceride (mg/dL) | 140 ± 17 | 109 ± 7 | 38.4 (−0.4 to 77.3) |
| Blood sugar (mg/dL) | 115 ± 8 | 105 ± 5 | 18.0 (1.8 to 34.2) |
| ALP (U/L) | 244 ± 15 | 241 ± 13 | −0.8 (−14.3 to 12.7) |
| LDH (U/L) | 197 ± 6 | 209 ± 6 | −10.8 (−17.8 to −3.8) |
| AST (U/L) | 24 ± 2 | 25 ± 2 | −0.9 (−2.7 to 0.8) |
| ALT (U/L) | 23 ± 4 | 25 ± 4 | −2.2 (−5.0 to 0.7) |
| G-GTP (U/L) | 36 ± 6 | 40 ± 6 | −5.4 (−10.5 to −0.4) |
| BUN (mg/dL) | 17 ± 1 | 23 ± 2 | −6.4 (−9.1 to −3.6) |
| Cr (mg/dL) | 0.84 ± 0.05 | 0.82 ± 0.05 | 0.0 (−0.0 to 0.1) |
| CRP (mg/dL) | 0.34 ± 0.14 | 0.26 ± 0.09 | 0.1 (−0.1 to 0.3) |
From: Impact of Preoperative Immunonutritional Support in Patients Undergoing Elective Thoracic Surgery
| Items | Baseline | After support | Mean difference (95% CI) |
|---|---|---|---|
| Body mass index | 23.0 ± 0.5 | 22.5 ± 0.8 | −0.2 (−0.4 to 0.1) |
| Geriatric nutritional risk index | 104.1 ± 1.2 | 104.5 ± 1.9 | 1.8 (0.3 to 3.2) |
| Prognostic nutritional index | 40.8 ± 0.7 | 41.7 ± 0.7 | 1.5 (0.2 to 2.7) |
From: Impact of Preoperative Immunonutritional Support in Patients Undergoing Elective Thoracic Surgery
| Items | Control group (n = 34) | Immunonutritional support group (n = 34) | P value |
|---|---|---|---|
| Gender | 0.3306 | ||
| Male | 14 | 18 | |
| Female | 20 | 16 | |
| Age, median (range) | 74 (49-87) | 74 (46-89) | 0.7540 |
| ECOG-PS | 0.7337 | ||
| 0 | 28 | 30 | |
| 1 | 6 | 4 | |
| Smoking status | 0.7854 | ||
| Non | 18 | 16 | |
| Former | 15 | 16 | |
| Current | 1 | 2 | |
| Preoperative comorbidities | 0.7794 | ||
| No | 8 | 9 | |
| Yes | 26 | 25 | |
| Preoperative diagnosis | 0.9525 | ||
| Lung cancer | 25 | 24 | |
| Metastatic lung tumors | 6 | 7 | |
| Others | 3 | 3 | |
| Immunonutritional supplements | - | ||
| IMPACTⓇ | - | 19 | |
| MEINⓇ | - | 12 | |
| AboundⓇ | - | 3 |
